Abstract
dc:descriptionIN THE PRESENT STUDY 76 MYELOMA PATIENTS ANALYSED KARYOTYPICALLY AND IN 38 (50%) A CLONAL ABNORMALITY WAS IDENTIFIED. CHROMOSOMAL ABNORMALITIES THAT COULD BE CONSIDERED AS PRIMARY INVOLVED MAINLY CHROMOSOMES 14, 10, 6, 1 AND 22 (STRUCTURAL) AND 13, 15, 17 AND 22 (NUMERICAL). SECONDARY WERE FOUND MAINLY ON CHROMOSOMES 1, 2, 5, 6, 12, 14, 22. THE MOST FREQUENTLY IDENTIFIED BREAKPOINTS WERE 14Q32, 10Q24-25, 1P11-13, 1P32, 1P36, 2P23, 5Q13-22, 22Q11-12, 6Q24-25. THE ABOVE 3 CASES WITH T(11;14) HAD A GOOD RESPONSE TO TREATMENT. REARRANGEMENTS OF CHROMOSOME 14 INVOLVING CHROMOSOMES 5, 8, 10, 12 AND 15 WERE OF POOR PROGNOSIS. THE PRESENCE OF A PH CHROMOSOME IN CASES OF MYELOMA IS OF INTEREST INVIEW OF THE EVIDENCE OF MYELOID MARKUS IN PLASMA CELLS OF SOME MYELOMA PATIENTS. CHROMOSOME 1 WAS THE MOST FREQUENTLY INVOLVED CHROMOSOME BOTH IN STRUCTURAL AND NUMERICAL ANOMALIES (22%). CHROMOSOME 14 IN 21%, CHROMOSOME 10 IN 18%, CHROM. 6IN 16%, CHROM.15 IN 14%, CHROM. 22 IN 12%, CHROM. 2 IN 9%, CHROM.5 IN 10%, AND CHROMOSOMES 12, 17 AND X IN 5% OF CASES. OF INTEREST IS ALSO THE FACT THAT A MEMBER OF CHROMOSOMAL BREAKPOINTS WERE IDENTICAL IN PATIENTS BEFORE THERAPY AS WELL AS IN THOSE THAT HAD RECEIVED CHEMOTHERAPY. IN THE SAMEBREAKPOINTS HAVE BEEN IDENTIFIELD MOST OF IMPORTANT GENES WHICH WERE INVOLVED IN MALIGNANT TRANSFORMATION AND IN THE BIOLOGIC PROCESSES OF CELL DIVISION AND DIFFERENTIATION.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 1994
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Δερμιτζάκη-Καρδάση, Κρυστάλλω
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/3394